000			01633 a2200469 4500
005			20250516103223.0
264		0	_c20121207
008			201212s 0 0 eng d
022			_a1572-0241
024	7		_a10.1038/ajg.2012.211 _2doi
040			_aNLM _beng _cNLM
100	1		_aLeffler, Daniel A
245	0	0	_aA randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge. _h[electronic resource]
260			_bThe American journal of gastroenterology _cOct 2012
300			_a1554-62 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAcute Disease
650	0	4	_aAdult
650	0	4	_aCeliac Disease _xprevention & control
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aGastrointestinal Agents _xtherapeutic use
650	0	4	_aGlutens _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOligopeptides _xtherapeutic use
650	0	4	_aSecondary Prevention _xmethods
650	0	4	_aSeverity of Illness Index
650	0	4	_aTight Junctions _xdrug effects
700	1		_aKelly, C P
700	1		_aAbdallah, H Z
700	1		_aColatrella, A M
700	1		_aHarris, L A
700	1		_aLeon, F
700	1		_aArterburn, L A
700	1		_aPaterson, B M
700	1		_aLan, Z H
700	1		_aMurray, J A
773	0		_tThe American journal of gastroenterology _gvol. 107 _gno. 10 _gp. 1554-62
856	4	0	_uhttps://doi.org/10.1038/ajg.2012.211 _zAvailable from publisher's website
999			_c21968856 _d21968856